Lilly Adds To In Vivo CAR-T Capabilities With Kelonia Buyout

 
• By Joseph Haas
  
This is a picture of the Lilly building in San Diego
Lilly's latest M&A deal adds Kelonia's in vivo CAR-T technology (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business